Molecular Diagnostics Market Huge Growth |Posted by Sujeet Nakade on February 26th, 2020 Molecular Diagnostics Market study presents basic data and true figures about the market giving a general assessable analysis of this market based on market drivers, market trends, constraints and its future prospects. The report supplies the worldwide monetary challenge with the help of Porter’s Five Forces Analysis and SWOT Analysis. Some of the major players operating in the global molecular diagnostics market are Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic Corporation, Qiagen, Myriad Genetics, Cepheid Inc., Genomic Health Inc., Grifols Sa, Bayer Healthcare, Johnson & Johnson, Dalko Diagnostics, Sysmex Corporation, Illumina, Qiagen N.V., Novartis AG, Cepheid, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific among others. The global molecular diagnostics market is expected to reach USD 13.9 billion by 2025, from USD 7.1 billion in 2017 growing at a CAGR of 8.8% during the forecast period of 2018 to 2025. Interesting? Apply for a sample report:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-molecular-diagnostics-market By Product & Service (Reagents & Kits, Instruments, Services & Software), By Application (Infectious Diseases {Hepatitis, HIV, CT/NG, HAIs, HPV, TB}, Oncology {Breast Cancer, Lung Cancer, Colorectal Cancer}, Genetic Tests), By Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization), By End User, By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Major Market Drivers and Restraints: High prevalence of infectious diseases and various types of cancers. Increasing awareness and acceptance of personalized medicine and companion diagnostics. Growth in the biomarker identification market and advancements in molecular techniques. Complex regulatory frameworks delaying the approval of new molecular diagnostic tests. Table of Contents 1 Market Overview 2 Manufacturers Profiles 3 Global Molecular Diagnostics Market Competitions, by Manufacturer 4 Global Molecular Diagnostics Market Analyses by Regions 5 North America Molecular Diagnostics by Countries 6 Europe Molecular Diagnostics by Countries 7 Asia-Pacific Molecular Diagnostics by Countries 8 South America Molecular Diagnostics by Countries 9 Middle East and Africa Molecular Diagnostics by Countries 10 Global Molecular Diagnostics Market Segment by Type 11 Global Molecular Diagnostics Market Segment by Application 12 Sales Channel, Distributors, Traders and Dealers 13 Research Findings and Conclusion 14 Appendixes
Molecular diagnostics market is increasing with the very high rate. These are the tests that are used to detect specific sequences in DNA or RNA that may or may not be associated with disease, including single nucleotide polymorphism (SNP), insertions, rearrangements, deletions and others. The clinical applications of molecular diagnostics can be found in at least six wide-ranging areas that are oncology, pharmacogenomics, human leukocyte antigen typing, infectious diseases, genetic disease screening and coagulation. Three basic steps are required for each molecular analysis, The first step is extraction and purification of nucleic acid, followed by the second step that is amplification or making copies of the nucleic acid of interest (target) or attaching multiple copies of a dye to a single target copy, and third and the last step is the detection of the amplified target using real time polymerase chain reaction (PCR) or end product detection including microarrays, Lumina i.e. similar to flow cytometry or sequencing. All the three steps can be performed together or separately according to the convenience of the doctors and physicians. At the association of molecular pathology (AMP), Food and Drug Administration (FDA) has cleared molecular tests that can be modified by a laboratory, through these tests nucleic acid extractor (that differs from the extractors) can be validated. The other example is laboratory validation of a specimen type, which is already approved by the FDA. For instance, ASR (Analyte Specific Reagents) can be used for patient specimens after in-house validation. RUO (Research Use Only) which is usually referred to tests and rarely to devices. Market Segment by Regions, regional analysis covers:
Some of the important question for stakeholders and business professional for expanding their position in the Global Molecular Diagnostics Market:
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market Contact: Data Bridge Market Research Tel: +1-888-387-2818 Like it? Share it! More by this author |